Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK LIFE SCIENCES Gains 6%; BSE HEALTHCARE Index Up 0.7%
Wed, 3 Jul 11:36

GLENMARK LIFE SCIENCES Gains 6%; BSE HEALTHCARE Index Up 0.7%Image source: Eoneren/www.istockphoto.com

GLENMARK LIFE SCIENCES share price has zoomed 6% and is presently trading at Rs 936.2.

Meanwhile, the BSE HEALTHCARE index is at 37,403.6 (up 0.7%).

Among the top gainers in the BSE HEALTHCARE index today are SUN PHARMA ADV. RES. (up 2.8%) and FORTIS HEALTHCARE (up 2.7%).

ALEMBIC PHARMA (down 2.0%) and AARTI DRUGS (down 1.7%) are among the top losers today.

Over the last one year, GLENMARK LIFE SCIENCES has moved up from Rs 573.0 to Rs 936.2, registering a gain of Rs 363.2 (up 63.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 37,403.6, registering a gain of 46.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 90.7%), Cadila Healthcare (up 90.1%) and GSK Pharma (up 87.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,874.1 (up 0.5%).

The top gainers among the BSE Sensex today are HDFC Bank (up 3.1%) and Axis Bank (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 24,265.5 (up 0.6%). HDFC Bank and Tata Consumer Products are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 79,874.1, registering a gain of 14,669.0 points (up 22.5%).

GLENMARK LIFE SCIENCES Financial Update...

GLENMARK LIFE SCIENCES net profit fell 33.1% YoY to Rs 979 million for the quarter ended March 2024, compared to a profit of Rs 1,464 million a year ago. Net sales declined 13.6% to Rs 5,366 million during the period as against Rs 6,213 million in January-March 2023.

For the year ended March 2023, GLENMARK LIFE SCIENCES reported 11.5% increase in net profit to Rs 4,670 million compared to net profit of Rs 4,187 million during FY22. Revenue of the company grew 1.8% to Rs 21,612 million during FY23.

The current Price to earnings ratio of GLENMARK LIFE SCIENCES, based on rolling 12 month earnings, stands at 24.4.


Equitymaster requests your view! Post a comment on "GLENMARK LIFE SCIENCES Gains 6%; BSE HEALTHCARE Index Up 0.7%". Click here!